• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

VNA or PACS-centric Models Lead Enterprise Imaging Plans

Article

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, KLAS found.

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, according to a new KLAS report.

The report, Enterprise Imaging 2012: Provider’s Strategies and Insights, found that most providers are in the early stages of forming the strategy that would allow access to images at the right time and place, according to market research firm KLAS.

"Image storage is a necessity, no matter what option is chosen," said Ben Brown, imaging research director and author of the report. "As providers start to bring in more studies and the studies themselves increase in size, the need for storage will increase. In addition, as a provider explained, images will need to be managed as well as stored."

Of the providers interviewed, 27 percent said that a vendor-neutral archive (VNA) would be central to their strategy. This option was selected most often by hospitals with more than 500 beds. A PACS-centric archive solution was selected by 25 percent of providers, most of them facilities with fewer than 500 beds.

GE and Philips were mentioned most often by those interviewed, and customers said they considered their vendor to be part of the imaging strategy moving forward, particularly for a PACS-centric approach. Fuji also has a strong PACS enterprise archive offering, according to KLAS. Agfa and Merge were most often cited for VNA approaches.

Provider Reported Enterprise Imaging Strategy:


 chart credit: KLAS

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.